Premier Alternatives

ABK Biomedical

Halifax, Canada · Founded 2012 · Privately Held (backing)

Developer of a microsphere product designed to improve the treatment of hypervascular tumors. ABK Biomedical is based in Halifax, Canada and was founded in 2012. Its last reported valuation was $73 million in Dec 2022. It has raised $122 million across 4 recorded rounds; the latest was a $2.6 million seed round in Oct 2025.

Last reported valuation
$73.0M
Oct 2026
Priced at
—
Total raised
$121.7M
Last round
Seed Round
Oct 2025

ABK Biomedical key facts

as of Oct 2026
  • Developer of a microsphere product designed to improve the treatment of hypervascular tumors.
  • ABK Biomedical is valued at approximately $73.0M as of Oct 2026 (last reported valuation).
  • It has raised $121.7M across 4 recorded rounds; the latest was Seed Round ($2.6M) in Oct 2025.
  • Notable investors include F-Prime Capital, Eight Roads, Invest Nova Scotia, PIC Investment Group, Atlantic Canada Opportunities Agency — 11 tracked in total.
  • ABK Biomedical has filed 4 Form Ds with the SEC since 2019, most recently May 2025 ($26.1M sold to 24 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$73.0M

ABK Biomedical's last reported valuation, Dec 2022. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of ABK Biomedical with a free account
  • ·The complete investor list: 11 names
  • ·Watch ABK Biomedical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

ABK Biomedical funding rounds

4 rounds
Oct 2025Seed Round$2.6MSEC filing▮
Apr 2025Early Stage VC$26.1MSEC filing▮
Sep 2022Early Stage VC$28.5MSEC filing▮
Apr 2019Early Stage VC$23.5MSEC filing▮
Full funding history →

ABK Biomedical valuation

ABK Biomedical's last reported valuation was $73 million in Dec 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has ABK Biomedical raised?

ABK Biomedical has raised $122 million across 4 recorded rounds since 2019. The largest was a $28.5 million early-stage round in Sep 2022; the most recent was a $2.6 million seed round in Oct 2025.

ABK Biomedical has filed 4 Form Ds with the SEC since 2019, most recently in May 2025 ($26.1 million sold to 24 investors).

ABK Biomedical investors

11 investors are on record for ABK Biomedical, including F-Prime Capital, Eight Roads, Invest Nova Scotia and PIC Investment Group. The seed round in Oct 2025 drew 6 investors.

About ABK Biomedical

Developer of a microsphere product designed to improve the treatment of hypervascular tumors. The company's product is a novel radiopaque bland embolic and beta radiation emitting agent that helps to improve the targeting of tumor vascularity and tumor tissue, enabling doctors to help standardize, optimize, and personalize minimally invasive therapies.

Sector
Healthcare
HQ
Halifax, Canada
Founded
2012
Employees
41
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.